Professional Documents
Culture Documents
Drug Study
Drug Study
Naproxen nonopioid Inhibits Mild to Hypersensitivity; CNS: dizziness, Patients who have
(Aleve, analgesics, prostaglandin moderate Cross-sensitivity may drowsiness, headache. asthma, aspirin-induced
Anaprox, nonsteroidal anti- synthesis. pain. occur with other EENT: tinnitus, visual allergy, and nasal
Anaprox inflammatory Dysmenorrh NSAIDs, including disturbances. Resp: polyps are at increased
DS, agents (NSAIDs), ea. Fever. aspirin; Active GI dyspnea. CV: HF, risk for developing
Maxidol, antipyretics Inflammatory bleeding; Ulcer MYOCARDIAL hypersensitivity
EC- disorders, disease; Coronary INFARCTION, reactions. Assess for
Naprosyn, including: artery bypass graft STROKE, edema, rhinitis, asthma, and
Naprelan, Rheumatoid (CABG) surgery; hypertension, urticaria.
Naprosyn) arthritis Lactation: Passes into palpitations,
(adults and breast milk and should tachycardia. F and E: Monitor BP during
children), not be used by nursing hyperkalemia. GI: initiation and
Osteoarthriti mothers DRUG-INDUCED periodically during
s. HEPATITIS, GI therapy.
BLEEDING,
constipation, Assess for rash
dyspepsia, nausea, periodically during
anorexia, diarrhea, therapy. May cause
discomfort, flatulence, Stevens-Johnson
vomiting. GU: cystitis, syndrome. Discontinue
hematuria, renal therapy if severe or if
failure. accompanied with
fever, general malaise,
Derm: photosensitivity, fatigue, muscle or joint
rashes, sweating, aches, blisters, oral
pseudoporphyria (12% lesions, conjunctivitis,
incidence in children hepatitis and/or
with juvenile eosinophilia
rheumatoid arthritis—
discontinue therapy if Assess pain (note type,
this occurs). location, and intensity)
prior to and 1– 2 hr
Hemat: blood following administration.
dyscrasias, prolonged
bleeding time. Assess pain and range
of motion prior to and
Misc: allergic reactions 1– 2 hr following
including administration
ANAPHYLAXIS and
STEVENS-JOHNSON Monitor temperature;
SYNDROME. note signs associated
with fever (diaphoresis,
tachycardia, malaise).
ethinyl contraceptive Ovulation is Prevention Hypersensitivity; OB: CNS: depression, Assess BP before and
estradiol/no hormones inhibited by of Pregnancy; History of headache. EENT: periodically during
rgestimate suppression pregnancy. cigarette smoking or contact lens therapy.
(Ortho Tri- of FSH and Regulation age 35 yr (q risk of intolerance, optic
Cyclen, LH. May alter of menstrual cardiovascular or neuritis, retinal Exclude the possibility
Ortho Tri- cervical cycle. thromboembolic thrombosis. CV: of pregnancy on the
Cyclen Lo, mucus and Treatment of phenomenon); History THROMBOEMBOLIS basis or history and/or
the heavy of thromboembolic M (risk is greatest physical exam or a
Tri- endometrial menstrual disease (e.g., DVT, during first 6 mo of pregnancy test before
Estarylla, environment, bleeding in PE, MI, stroke); Protein therapy or after administering
Tri-Linyah, preventing women who C, protein S, or restarting the same or emergency
Tri-Lo- penetration choose to antithrombin deficiency different therapy), contraceptives.
Estarylla, by sperm and use or other thrombophilic edema, hypertension,
Tri-Lo-Mili, implantation intrauterine disorder; Valvular heart Raynaud’s Assess skin lesion
Tri- of the egg. contraceptio disease; Major surgery phenomenon, before and periodically
Previfem,
TriSprintec, Varying n as their with extended periods thrombophlebitis. GI: during therapy.
TriNessa) doses of method of of immobility; Diabetes PANCREATITIS,
estrogen/prog contraceptio with vascular abdominal cramps, Menopausal
estin may n. involvement; bloating, cholestatic Symptoms: Assess
more closely Headache with focal jaundice, gallbladder vasomotor symptoms or
mimic natural neurological disease, liver tumors, symptoms of vulvar and
hormonal symptoms; nausea, vomiting. GU: vaginal atrophy due to
fluctuations. Uncontrolled amenorrhea, menopause prior to and
hypertension; History breakthrough bleeding, periodically during
of breast, endometrial, dysmenorrhea, therapy.
or estrogen-dependent spotting, Intrauterine
cancer; Abnormal Derm: melasma, rash.
genital bleeding; Liver Endo: hyperglycemia.
disease; MS: Injectable
Hypersensitivity to medroxyprogesterone
parabens only—bone loss. Misc:
weight change.
If oral contraceptives
are used, use
alternative
contraception.
Report diarrhoea,
cramping and blood in
stools as
pseudomembranous
colitis may occur.
magaldrate antacids Neutralize Useful in a Severe abdominal pain GI: aluminum salts— Assess for heartburn
with gastric acid variety of GI of unknown cause, constipation; and indigestion as well
simethicone following complaints, especially if magnesium salts, as location, duration,
(Riopan dissolution in including: accompanied by fever; diarrhea. F and E: character, and
Plus) gastric Hyperacidity, Renal failure (CrCl 30 magnesium salts— precipitating factors of
contents. Indigestion, mL/min); Products hypermagnesemia; gastric pain
Inactivate GERD, containing tartrazine or aluminum salts,
pepsin if pH Heartburn. sugar in patients with hypophosphatemia.
is raised to 4. known intolerance.
Therapeutic
Effects:
Neutralization
of gastric acid
with healing
of ulcers and
decrease in
associated
pain.
Medical Card
1. Low-dose OC: Norgestimate 0.25mg/ethinyl estradiol 35mcg 1 tablet PO daily for 28 days q.d.
456 Patient X
10 am
Norgestimate 0.25mg/ethinyl estradiol 35mcg
1 tablet QD
QMC
Obstetrics and Gynecology Dept
Talia G. Hamed
BSN II -SLSU
Jan 28, 2022/1:00 p.m.
Patient X
456
10 am Naproxen 550 mg
QMCprn
1 tablet
Obstetrics and Gynecology Dept
Talia G. Hamed
BSN II -SLSU
Jan 28, 2022/1:00 p.m.
3. Co-amoxiclav 625 mg 1 tablet PO BD for 7 days
456
8 am –
1pm
Patient X
Co-amoxiclav 625 mg
1 tablet bd
QMC
Obstetrics and Gynecology Dept
Talia G. Hamed
BSN II -SLSU
Jan 28, 2022/1:00 p.m.
4. Antacid with Simeticone 1 tablet PO TDS for gastric discomfort
456 Patient X
8 am –
1pm – 6 Antacid with Simeticone
pm
1 tablet tds
QMC
Obstetrics and Gynecology Dept
Talia G. Hamed
BSN II -SLSU
Jan 28, 2022/1:00 p.m.
Patient X
456
8 am – IVF of D5LR 1 liter
4pm 1 iv q8h
QMC
Obstetrics and Gynecology Dept
Talia G. Hamed
BSN II -SLSU
Jan 28, 2022/1:00 p.m.
6. 2 “u” PRBC (Packed Red Blood Cells ) properly type and crossmatched
Patient X
QMC
Obstetrics and Gynecology Dept
Talia G. Hamed
BSN II -SLSU
Jan 28, 2022/1:00 p.m.